Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$237,799
-$51,027 QoQ
Shares Held
945
-28.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#3,823
of 4,153 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Diest Capital, LLC holds $2,816,193 across 8 Drug Manufacturers - General names. ABBV ranks #7 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,153 | $546,797 | |
| 2 | LLY |
ELI LILLY & Co
|
436 | $522,951 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,230 | $474,212 | |
| 4 | NVS |
Novartis AG
|
1,832 | $287,111 | |
| 5 | AMGN |
Amgen Inc
|
745 | $269,779 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,892 | $243,122 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
945 | $237,799 | |
| 8 | GSK |
GSK plc
|
4,472 | $234,422 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,799 | 945 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $288,826 | 1,328 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $251,567 | 1,101 | Shares | Sole | 2026-02-19 | |
| No filing history on record for this holder in this stock. | ||||||